News

British Columbia’s first dedicated inpatient clinical trials unit for early-phase therapies in blood cancers has been launched by Vancouver Coastal Health in collaboration with BC Cancer physicians and scientists. Located at Vancouver General Hospital (VGH), the new Hematology Research Unit will deliver revolutionary therapies — including first-in-human treatments such as advanced immunotherapies like CAR T-cell therapy — to patients with relapsed or treatment-resistant hematological diseases.

Congratulations to the recipients of the BC Cancer Foundation (BCCF) 2024 Rising Stars Award competition!

This year’s awardees are: 

BC Cancer researchers receive Cancer Research Society’s Doctoral Research Awards

Three BC Cancer graduate students are 2024 recipients of Doctoral Research Awards from the Cancer Research Society (CRS), receiving new funding to support their innovative research aimed at better understanding cancer.

Doctoral Research Awards recipients 

Doctoral Research Awards invests in the future of cancer research through the support of graduate students pursuing cancer research at an eligible Canadian institution.

BC Cancer’s 2024 Cancer Emerging Multidisciplinary Research Programs supports research teams to initiate novel multidisciplinary research projects that aim to tackle well-defined issues or problems that affect patients living with cancer or at risk of developing cancer. Funding for the programs is provided through the BC Ministry of Health in collaboration with the BC Cancer Foundation.

2024 Emerging Multidisciplinary Research Programs Recipients: 

Congratulations to Lorenzo Lindo of Hay Lab (Terry Fox Laboratory) for receiving a Canadian Cancer Society (CCS) Research Training Award, with joint funding from the Terry Fox Research Institute (TFRI).

The award is tied to the project titled, "Engineering CAR-T Cells to Overcome Immune Suppression and Enhance Efficacy in Multiple Myeloma.”

Dr. Poul Sorensen (Molecular Oncology), with co-investigators Dr. Kevin Hay (Terry Fox Laboratory) and Dr. Wei Li (University of Pittsburgh), received a Project Grant from the Canadian Institutes of Health Research (CIHR) for their project titled, “Targeting metabolic vulnerabilities in childhood cancers using immunotherapy.”